|
Post-transplant Cyclophosphamide (PTCy) Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Cytoxan
Washington D.C., District of Columbia1 trial
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.